Healthcare Investment Opportunities PLC completed the acquisition of Collbio Ltd. from Diagnostic Capital, Investment Arm, David Evans and Kevin Wilson and others.
As at September 30, 2013, Collbio had gross assets of £0.14 million. The existing Collbio personnel will be retained in senior management roles. Stewart White, current Chief Executive Officer of Collbio, will join the Board, upon Admission, as Chief Executive Officer. The transaction is subject to the approval of Collbio's shareholders at a general meeting to be held on December 27, 2013. The Independent Director recommended that shareholders vote in favour of all of the deal at the General Meeting.
Ross Andrews, John Depasquale, John Goold and Dominic Wilson of Zeus Capital Limited acted as Nnominated adviser and broker for Healthcare Investment Opportunities PLC. Paul McManus and Mike Wort of Walbrook PR Ltd acted as public relation advisor for Healthcare Investment Opportunities PLC. Cairn Financial Advisers LLP acted as financial advisor for independent Director of Healthcare Investment Opportunities PLC. Baker Tilly Corporate Finance LLP acted as accountant and DWF LLP as legal advisor to Healthcare Investment Opportunities. Capita Asset Services acted as registrar to Healthcare Investment. BPE Solicitors LLP acted as legal advisor to Zeus.
Healthcare Investment Opportunities PLC (AIM:HIO) completed the acquisition of Collbio Ltd. from Diagnostic Capital, Investment Arm, David Evans and Kevin Wilson and others on January 2, 2014. Healthcare Investment Opportunities' name was changed to Collagen Solutions PLC and will be headed by Collbio's Chief Executive Officer, Stewart White.